Nabriva Therapeutics AG (NBRV)
(Delayed Data from NSDQ)
$2.16 USD
+0.01 (0.47%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.16 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Gross Margin (TTM)
The Company's trailing twelve month (TTM) Gross Margin is based on the amount a company spends to produce its products or services. The Gross Margin is the total revenue (equivalent to total sales) minus the cost of goods sold. A company with modest sales and high gross margin is in a good position to become more profitable if sales are increased.